Good morning Sunny... and it was a FOURTH request

Good morning Sunny... and it was a FOURTH request if I heard correctly from Dr. Lalezari...

In the PR Monday 5/18, there was this statement:

Quote:

---

CytoDyn plans to update the public regarding current eIND results later this week.

---

In the PR Tuesday 5/19, there was this statement:

Quote:

---

CytoDyn has been granted more than sixty emergency Investigational New Drug (eIND) authorizations by the U.S. Food and Drug Administration (FDA) and plans to provide clinical updates for this patient population later in the week.

---

No actual follow up on either of these two so we get a PR at the unusual late hour on a Friday before a holiday weekend to address the above... and apparently more... in a conf. call Tuesday. Hopefully by late Tuesday after a potentially fruitful long holiday weekend (four days actually) as there are still people dying daily... the "results" and "clinical updates" should be even more informative and I suspect more impressive.

And there's sure be more than that based on the PR late this Friday evening:

Quote:

---

... Conference Call to Provide Updates on COVID-19 (Phase 2, 3 & eIND), Cancer (mTNBC, Phase 2 for 22 Solid Tumor Cancers), HIV (BLA, Monotherapy), NASH, GvHD and MS

... to provide a comprehensive update on several recent clinical and regulatory developments

---

Just wish we can get Leronlimab to many more faster and save lives....